CRMD News and Press, CorMedix Inc. From 04/11/19

BERKELEY HEIGHTS, NJ / ACCESSWIRE / April 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that on Friday, April ...

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 25, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today confirmed that the previously an...

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will p...

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 7, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its...

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 4, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that Alan W. Dunton, M....

HENDERSON, NV / ACCESSWIRE / February 20, 2019 / Biotech may have had a hard 2018, but the sector is making up for lost time at the start of this year. This may be just getting started as many fund managers are underweight in the industry and may have to chase this run. One more under the ra...

Gainers:  Invacare (NYSE: IVC ) +69% . Reebonz Holding ( RBZ ) +38% . Arcimoto (NASDAQ: FUV ) +35% . Electrameccanica Vehicles (NASDAQ: SOLO ) +21% . CyberArk Software (NASDAQ: CYBR ) +20% . Outlook Therapeutics (NASDAQ: OTLK ) +20% . GWG Holdings (NASDAQ: GWGH ) +19% . Ma...

CorMedix ( CRMD -17.8% ) is down on double normal volume on the heels its update on its talks with the FDA about its planned marketing application seeking approval for Neutrolin as a catheter lock solution in patients with end-stage renal disease on hemodialysis. More news on: CorMedix...

Motif Bio (NASDAQ: MTFB ) -75%  on receiving CRL from FDA. More news on: Motif Bio, Inovio Pharmaceuticals, Inc., Sierra Wireless, Inc., Stocks on the move, Read more ...

Cleared to Request Approval Under LPAD; FDA to Review LOCK-IT-100 Clinical Data BERKELEY HEIGHTS, NJ / ACCESSWIRE / February 14, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and ...